20 Multi-Year Registry Study of Elapegademase-lvlr Treatment in Patients with Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Therapy (ERT)
CLINICAL IMMUNOLOGY（2024）
关键词
ADA-SCID,Enzyme replacement therapy,Adenosine deaminase severe combined immunodeficiency,HSCT,Registry,Immunodeficiency
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要